The Korean Journal of Pain

The Korean Pain Society (대한통증학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of cyanocobalamin and its combination with morphine on neuropathic rats and the relationship between these effects and thrombospondin-4 expression

  • Duzenli, Neslihan (Department of Medical Pharmacology, Faculty of Medicine, Ege University) ;
  • Ulker, Sibel (Department of Medical Pharmacology, Faculty of Medicine, Ege University) ;
  • Sengul, Gulgun (Department of Anatomy, Faculty of Medicine, Ege University) ;
  • Kayhan, Buse (Department of Neuroscience, Faculty of Health Sciences, Ege University) ;
  • Onal, Aytul (Department of Medical Pharmacology, Faculty of Medicine, Ege University)
  • Received : 2021.09.16
  • Accepted : 2021.12.04
  • Published : 2022.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Thrombospondin-4 (TSP4) upregulates in the spinal cord following peripheral nerve injury and contributes to the development of neuropathic pain (NP). We investigated the effects of cyanocobalamin alone or in combination with morphine on pain and the relationship between these effects and spinal TSP4 expression in neuropathic rats. Methods: NP was induced by chronic constriction injury (CCI) of the sciatic nerve. Cyanocobalamin (5 and 10 mg/kg/day) was administered 15 days before CCI and then for 4 and 14 postoperative days. Morphine (2.5 and 5 mg/kg/day) was administered only post-CCI. Combination treatment included cyanocobalamin and morphine, 10 and 5 mg/kg/day, respectively. All drugs were administered intraperitoneally. Nociceptive thresholds were detected by esthesiometer, analgesia meter, and plantar test, and TSP4 expression was assessed by western blotting and fluorescence immunohistochemistry. Results: CCI decreased nociceptive thresholds in all tests and induced TSP4 expression on the 4th postoperative day. The decrease in nociceptive thresholds persisted except for the plantar test, and the increased TSP4 expression reversed on the 14th postoperative day. Cyanocobalamin and low-dose morphine alone did not produce any antinociceptive effects. High-dose morphine improved the decreased nociceptive thresholds in the esthesiometer when administered alone but combined with cyanocobalamin in all tests. Cyanocobalamin and morphine significantly induced TSP4 expression when administered alone in both doses for 4 or 14 days. However, this increase was less when the two drugs are combined. Conclusions: The combination of cyanocobalamin and morphine is more effective in antinociception and partially decreased the induced TSP4 expression compared to the use of either drug alone.

Keywords

Acknowledgement

We would like to thank Gurhan Mutlu from the Department of Pharmacology, School of Medicine, Ege University, for his technical assistance.

References

  1. International Association for the Study of Pain. IASP terminology: neuropathic pain [Internet]. Washington, D.C.: IASP; 2021. Available at: https://www.iasp-pain.org/resources/terminology/#neuropathic-pain.
  2. Bouhassira D, Attal N. The multiple challenges of neuropathic pain. Neurosci Lett 2019; 702: 6-10. https://doi.org/10.1016/j.neulet.2018.11.054
  3. Zilliox LA. Neuropathic pain. Continuum (Minneap Minn) 2017; 23(2, Selected Topics in Outpatient Neurology): 512-32. https://doi.org/10.1212/con.0000000000000462
  4. Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic pain: central vs. peripheral mechanisms. Curr Pain Headache Rep 2017; 21: 28. https://doi.org/10.1007/s11916-017-0629-5
  5. Adams JC, Lawler J. The thrombospondins. Cold Spring Harb Perspect Biol 2011; 3: a009712. https://doi.org/10.1101/cshperspect.a009712
  6. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001; 107: 929-34. https://doi.org/10.1172/JCI12749
  7. Kim DS, Li KW, Boroujerdi A, Yu YP, Zhou CY, Deng P, et al. Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states. J Neurosci 2012; 32: 8977-87. https://doi.org/10.1523/JNEUROSCI.6494-11.2012
  8. Zeng J, Kim D, Li KW, Sharp K, Steward O, Zaucke F, et al. Thrombospondin-4 contributes to spinal cord injury-induced changes in nociception. Eur J Pain 2013; 17: 1458-64.
  9. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F. Underlying mechanisms of pro-nociceptive consequences of prolonged morphine exposure. Biopolymers 2005; 80: 319-24. https://doi.org/10.1002/bip.20254
  10. Hosseinzadeh H, Moallem SA, Moshiri M, Sarnavazi MS, Etemad L. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice. Arzneimittelforschung 2012; 62: 324-9. https://doi.org/10.1055/s-0032-1311635
  11. Xu G, Lv ZW, Feng Y, Tang WZ, Xu GX. A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia. Pain Med 2013; 14: 884-94. https://doi.org/10.1111/pme.12081
  12. Suzuki K, Tanaka H, Ebara M, Uto K, Matsuoka H, Nishimoto S, et al. Electrospun nanofiber sheets incorporating methylcobalamin promote nerve regeneration and functional recovery in a rat sciatic nerve crush injury model. Acta Biomater 2017; 53: 250-9. https://doi.org/10.1016/j.actbio.2017.02.004
  13. Zhang M, Han W, Zheng J, Meng F, Jiao X, Hu S, et al. Inhibition of hyperpolarization-activated cation current in medium-sized DRG neurons contributed to the antiallodynic effect of methylcobalamin in the rat of a chronic compression of the DRG. Neural Plast 2015; 2015: 197392. https://doi.org/10.1155/2015/197392
  14. Smith HS, Kara SD, Argoff CE. Management of neuropathic pain-current insights and future perspectives. US Neurol 2012; 8: 57-61. https://doi.org/10.17925/USN.2012.08.01.57
  15. Letizia Mauro G, Lauricella L, Vecchio M, Tomasello S, Scaturro D. Efficacy and tolerability of a fixed dose combination of cortex phospholipid liposomes and cyanocobalamin for intramuscular use in peripheral neuropathies. Minerva Med 2019; 110: 455-63.
  16. Buesing S, Costa M, Schilling JM, Moeller-Bertram T. Vitamin B12 as a treatment for pain. Pain Physician 2019; 22: E45-52.
  17. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107. https://doi.org/10.1016/0304-3959(88)90209-6
  18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75. https://doi.org/10.1016/S0021-9258(19)52451-6
  19. Austin PJ, Wu A, Moalem-Taylor G. Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats. J Vis Exp 2012; (61): 3393.
  20. Tsai YC, Sung YH, Chang PJ, Kang FC, Chu KS. Tramadol relieves thermal hyperalgesia in rats with chronic constriction injury of the sciatic nerve. Fundam Clin Pharmacol 2000; 14: 335-40. https://doi.org/10.1111/j.1472-8206.2000.tb00414.x
  21. Robinson I, Meert TF. Stability of neuropathic pain symptoms in partial sciatic nerve ligation in rats is affected by suture material. Neurosci Lett 2005; 373: 125-9. https://doi.org/10.1016/j.neulet.2004.09.078
  22. Maves TJ, Pechman PS, Gebhart GF, Meller ST. Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man. Pain 1993; 54: 57-69. https://doi.org/10.1016/0304-3959(93)90100-4
  23. Ro SL, Jacobs JM. The role of the saphenous nerve in experimental sciatic nerve mononeuropathy produced by loose ligatures: a behavioural study. Pain 1993; 52: 359-69. https://doi.org/10.1016/0304-3959(93)90170-T
  24. Bell AM, Hankison SJ, Laskowski KL. The repeatability of behaviour: a meta-analysis. Anim Behav 2009; 77: 771-83. https://doi.org/10.1016/j.anbehav.2008.12.022
  25. Park J, Yu YP, Zhou CY, Li KW, Wang D, Chang E, et al. Central mechanisms mediating thrombospondin-4-induced pain states. J Biol Chem 2016; 291: 13335-48. https://doi.org/10.1074/jbc.M116.723478
  26. Obata H, Sakurazawa S, Kimura M, Saito S. Activation of astrocytes in the spinal cord contributes to the development of bilateral allodynia after peripheral nerve injury in rats. Brain Res 2010; 1363: 72-80. https://doi.org/10.1016/j.brainres.2010.09.105
  27. Chiang CY, Sessle BJ, Dostrovsky JO. Role of astrocytes in pain. Neurochem Res 2012; 37: 2419-31. https://doi.org/10.1007/s11064-012-0801-6
  28. Pan B, Yu H, Park J, Yu YP, Luo ZD, Hogan QH. Painful nerve injury upregulates thrombospondin-4 expression in dorsal root ganglia. J Neurosci Res 2015; 93: 443-53. https://doi.org/10.1002/jnr.23498
  29. Li KW, Kim DS, Zaucke F, Luo ZD. Trigeminal nerve injury-induced thrombospondin-4 up-regulation contributes to orofacial neuropathic pain states in a rat model. Eur J Pain 2014; 18: 489-95. https://doi.org/10.1002/j.1532-2149.2013.00396.x
  30. Crosby ND, Zaucke F, Kras JV, Dong L, Luo ZD, Winkelstein BA. Thrombospondin-4 and excitatory synaptogenesis promote spinal sensitization after painful mechanical joint injury. Exp Neurol 2015; 264: 111-20. https://doi.org/10.1016/j.expneurol.2014.11.015
  31. Deng XT, Han Y, Liu WT, Song XJ. B vitamins potentiate acute morphine antinociception and attenuate the development of tolerance to chronic morphine in mice. Pain Med 2017; 18: 1961-74. https://doi.org/10.1093/pm/pnw358
  32. Qian C, Tan D, Wang X, Li L, Wen J, Pan M, et al. Peripheral nerve injury-induced astrocyte activation in spinal ventral horn contributes to nerve regeneration. Neural Plast 2018; 2018: 8561704. https://doi.org/10.1155/2018/8561704
  33. Hoffman JR, O'Shea KS. Thrombospondin expression in nerve regeneration I. Comparison of sciatic nerve crush, transection, and long-term denervation. Brain Res Bull 1999; 48: 413-20. https://doi.org/10.1016/S0361-9230(99)00021-0
  34. Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast 2013; 2013: 424651. https://doi.org/10.1155/2013/424651
  35. Holtman JR Jr, Crooks PA, Johnson-Hardy J, Wala EP. Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain. Eur J Pharmacol 2010; 648: 87-94. https://doi.org/10.1016/j.ejphar.2010.08.034
  36. Raghavendra V, Rutkowski MD, DeLeo JA. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002; 22: 9980-9. https://doi.org/10.1523/jneurosci.22-22-09980.2002
  37. Song P, Zhao ZQ. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001; 39: 281-6. https://doi.org/10.1016/S0168-0102(00)00226-1
  38. Hutchinson MR, Bland ST, Johnson KW, Rice KC, Maier SF, Watkins LR. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal 2007; 7: 98-111. https://doi.org/10.1100/tsw.2007.57
  39. Park JF, Yu YP, Gong N, Trinh VN, Luo ZD. The EGF-LIKE domain of thrombospondin-4 is a key determinant in the development of pain states due to increased excitatory synaptogenesis. J Biol Chem 2018; 293: 16453-63. https://doi.org/10.1074/jbc.RA118.003591
  40. Phamduong E, Rathore MK, Crews NR, D'Angelo AS, Leinweber AL, Kappera P, et al. Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes. ACS Chem Neurosci 2014; 5: 106-14. https://doi.org/10.1021/cn400172n
  41. Ikeda H, Miyatake M, Koshikawa N, Ochiai K, Yamada K, Kiss A, et al. Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation. J Biol Chem 2010; 285: 38415-27. https://doi.org/10.1074/jbc.M110.109827
  42. Ghazanfari S, Imenshahidi M, Etemad L, Moshiri M, Hosseinzadeh H. Effect of cyanocobalamin (vitamin B12) in the induction and expression of morphine tolerance and dependence in mice. Drug Res (Stuttg) 2014; 64: 113-7. https://doi.org/10.1055/s-0033-1355364
  43. Gomes FC, Paulin D, Moura Neto V. Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. Braz J Med Biol Res 1999; 32: 619-31. https://doi.org/10.1590/S0100-879X1999000500016
  44. Jones EV, Bouvier DS. Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease. Neural Plast 2014; 2014: 321209. https://doi.org/10.1155/2014/321209
  45. Jeon YH, Youn DH. Spinal gap junction channels in neuropathic pain. Korean J Pain 2015; 28: 231-5. https://doi.org/10.3344/kjp.2015.28.4.231
  46. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991; 565: 1-7. https://doi.org/10.1016/0006-8993(91)91729-K
  47. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; 2010: CD006605.
  48. Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 2019; 160: 53-9. https://doi.org/10.1097/j.pain.0000000000001365